Related references
Note: Only part of the references are listed.Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme
Carlos M. Gonzalez-Casimiro et al.
BIOMEDICINES (2021)
Hydroxypyridinethione Inhibitors of Human Insulin-Degrading Enzyme
Rebecca N. Adamek et al.
CHEMMEDCHEM (2021)
Targeting Insulin-Degrading Enzyme in Insulin Clearance
Malcolm A. Leissring et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme
Bikash R. Sahoo et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
Bacitracin attenuates haemolysis-induced insulin degradation during insulin sensitivity testing: Repurposing an old drug for use in metabolic research
Andrew P. Demidowich et al.
DIABETES OBESITY & METABOLISM (2020)
Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40
Caitlin N. Suire et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice
Beatriz Merino et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Quantitative, High-Throughput Assays for Proteolytic Degradation of Amylin
Caitlin N. Suire et al.
METHODS AND PROTOCOLS (2020)
Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme
Juan Pablo Maianti et al.
NATURE CHEMICAL BIOLOGY (2019)
Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity
Cristina M. Fernandez-Diaz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2019)
Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display
Caitlin N. Suire et al.
PLOS ONE (2018)
Insulin-degrading enzyme is not secreted from cultured cells
Eun Suk Song et al.
SCIENTIFIC REPORTS (2018)
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
Zhening Zhang et al.
ELIFE (2018)
Development and Characterization of Quantitative, High-Throughput-Compatible Assays for Proteolytic Degradation of Glucagon
Caitlin N. Suire et al.
SLAS DISCOVERY (2018)
Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice
Pablo Villa-Perez et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Inositol phosphates and phosphoinositides activate insulin-degrading enzyme, while phosphoinositides also mediate binding to endosomes
Eun Suk Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease
Sung Min Son et al.
AUTOPHAGY (2016)
Aβ-Degrading Proteases: Therapeutic Potential in Alzheimer Disease
Malcolm A. Leissring
CNS DRUGS (2016)
Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus
Wei-Jen Tang
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Age and Its Association with Low Insulin and High Amyloid-β Peptides in Blood
Huajie Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors
Samer O. Abdul-Hay et al.
ACS CHEMICAL BIOLOGY (2015)
Insulin-degrading enzyme is activated by the C-terminus of α-synuclein
Sandeep K. Sharma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo
Timothy B. Durham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Statins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway
Sung Min Son et al.
MOLECULAR NEURODEGENERATION (2015)
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice
Rebecca Deprez-Poulain et al.
NATURE COMMUNICATIONS (2015)
Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner
Sandeep K. Sharma et al.
SCIENTIFIC REPORTS (2015)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis
Julie Charton et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
Juan Pablo Maianti et al.
NATURE (2014)
The Type 2 Diabetes-Associated Gene Ide Is Required for Insulin Secretion and Suppression of α-Synuclein Levels in β-Cells
Par Steneberg et al.
DIABETES (2013)
Transcriptional Regulation of Insulin-degrading Enzyme Modulates Mitochondrial Amyloid β (Aβ) Peptide Catabolism and Functionality
Maria C. Leal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Optimization of Peptide Hydroxamate Inhibitors of Insulin-Degrading Enzyme Reveals Marked Substrate-Selectivity
Samer O. Abdul-Hay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Proteolytically Inactive Insulin-Degrading Enzyme Inhibits Amyloid Formation Yielding Non-Neurotoxic Aβ Peptide Aggregates
Matias B. de Tullio et al.
PLOS ONE (2013)
Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance
Samer O. Abdul-Hay et al.
PLOS ONE (2011)
Insulin-Degrading Enzyme Sorting in Exosomes: A Secretory Pathway for a Key Brain Amyloid-beta Degrading Protease
Ayelen Bulloj et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Molecular Basis for the Recognition and Cleavages of IGF-II, TGF-α, and Amylin by Human Insulin-Degrading Enzyme
Qing Guo et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
A Monomeric Variant of Insulin Degrading Enzyme (IDE) Loses Its Regulatory Properties
Eun Suk Song et al.
PLOS ONE (2010)
Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
Malcolm A. Leissring et al.
PLOS ONE (2010)
Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme
Marika Manolopoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme
Anthony DelleDonne et al.
MOLECULAR NEURODEGENERATION (2009)
Insulin-degrading enzyme is exported via an unconventional protein secretion pathway
Ji Zhao et al.
MOLECULAR NEURODEGENERATION (2009)
Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening
Christelle Cabrol et al.
PLOS ONE (2009)
Molecular Bases for the Recognition of Short Peptide Substrates and Cysteine-Directed Modifications of Human Insulin-Degrading Enzyme
Enrico Malito et al.
BIOCHEMISTRY (2008)
Amyloid β-degrading cryptidases:: insulin degrading enzyme, presequence peptidase, and neprilysin
E. Malito et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid β peptide -: Implications for Alzheimer disease pathogenesis
Ramiro E. Llovera et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Molecular basis for the thiol sensitivity of insulin-degrading enzyme
Marie Neant-Fery et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
In vitro and in vivo degradation of Aβ peptide by peptidases coupled to erythrocytes
Yinxing Liu et al.
PEPTIDES (2007)
Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE
Hookang Im et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The insulysin (insulin degrading enzyme) enigma
L. B. Hersh
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread
Qingxue Li et al.
CELL (2006)
Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism
Yuequan Shen et al.
NATURE (2006)
Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid β-protein
W Farris et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Insulin-degrading activity in wound fluid
WC Duckworth et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria
MA Leissring et al.
BIOCHEMICAL JOURNAL (2004)
Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
MA Leissring et al.
NEURON (2003)
Substrate activation of insulin-degrading enzyme (insulysin) - A potential target for drug development
ES Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Kinetics of amyloid β-protein degradation determined by novel fluorescence- and fluorescence polarization-based assays
MA Leissring et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme
RG Bennett et al.
JOURNAL OF ENDOCRINOLOGY (2003)
Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo
BC Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Prediction of peroxisomal targeting signal 1 containing proteins from amino acid sequence
G Neuberger et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Insulin-degrading enzyme exists inside of rat liver peroxisomes and degrades oxidized proteins
M Morita et al.
CELL STRUCTURE AND FUNCTION (2000)
Share Paper
